Article
Prostate tumor cells with cancer progenitor properties have high telomerase activity and are rapidly killed by telomerase interference
14 Feb 2011
Abstract excerpt
BACKGROUND: Cancer progenitor cells (CPCs) have been postulated to promote treatment resistance and disease progression in prostate and other malignancies. We investigated whether the enzyme telomerase, which is active in cancer cells and in normal stem cells, plays an important role in CPC which can be exploited to neutralize these cells. METHODS: We used flow cytometry and assays of gene expression,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
